PDGFRB and myeloproliferative neoplasm: PDGFRB-rearranged cases preferentially manifest as chronic myelomonocytic leukemia (CMML), and less frequently as CEL, MPN or atypical chronic myeloid leukemia (aCML) [1,3,29,30].